Time-course analysis of main markers of primary infection in cats with the feline immunodeficiency virus (Q454644)

From MaRDI portal
scientific article
Language Label Description Also known as
English
Time-course analysis of main markers of primary infection in cats with the feline immunodeficiency virus
scientific article

    Statements

    Time-course analysis of main markers of primary infection in cats with the feline immunodeficiency virus (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    10 October 2012
    0 references
    Summary: Studies of the response of the immune system to feline immunodeficiency virus (FIV) during primary infection have shown that a subpopulation of T-cells with an activated phenotype and reduced expression of the CD8 chain (denoted CD8 T cells) expands to reach up to 80\% of the total T cell count. The expansion of this subpopulation is considered to be a signature of FIV and an indicator of immune system alteration. We use a simple mathematical formalism to study the relationships over time between the dose of infection, the size of the CD8 population, and the circulating viral load in cats infected with FIV. Viremia profiles are described using a combination of two exponential laws, whereas the CD8 percentage (out of the total population) is represented by a Gompertz law including an expansion phase and a saturation phase. Model parameters are estimated with a population approach using data from 102 experimentally infected cats. We examine the dose of infection as a potential covariate of parameters. We find that the rates of increase of viral load and of CD8 percentage are both correlated with the dose of infection. Cats that develop strong acute viremia also show the largest degree of CD8 expansion. The two simple models are robust tools for analysing the time course of CD8 percentage and circulating viral load in FIV-infected cats and may be useful for generating new insights on the disease and on the design of therapeutic strategies, potentially applicable to HIV infection.
    0 references
    0 references
    feline immunodeficiency virus
    0 references
    primary infection
    0 references
    CD8 T cell subpopulation
    0 references
    0 references
    0 references
    0 references